World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
85
Citations
29329
World Ranking
3120
National Ranking
1579

Overview

Julien Sage is affiliated with Stanford University in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Oncology, Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine, and Cancer Research.

Their work covers various topics such as lung cancer research studies, neuroendocrine tumor research advances, cancer-related molecular pathways, lung cancer treatments and mutations, cancer genomics and diagnostics, cancer therapeutics and mechanisms, and epigenetics and DNA methylation.

Recent publications by Julien Sage include:

  • Small-cell lung cancer, 2021, Nature Reviews Disease Primers
  • Integrating Old and New Paradigms of G1/S Control, 2020, Molecular Cell
  • Mechanisms of small cell lung cancer metastasis, 2020, EMBO Molecular Medicine
  • Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication, 2022, Nature Medicine
  • Cells of origin of lung cancers: lessons from mouse studies, 2020, Genes & Development

Julien Sage collaborates frequently with the following co-authors:

  • Alexandros P. Drainas (17 publications)
  • Garry L. Coles (13 publications)
  • Myung Chang Lee (10 publications)
  • Yan Ting Shue (10 publications)
  • Monte M. Winslow (9 publications)

The scientist has published extensively in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory) with 15 publications
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature with 9 publications
  • Nature with 7 publications
  • Cancer Research with 6 publications
  • Journal of Thoracic Oncology with 4 publications

Best Publications

  • Comprehensive genomic profiles of small cell lung cancer

    Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Cellular mechanisms of tumour suppression by the retinoblastoma gene

    Deborah L. Burkhart;Julien Sage

  • Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.

    Charles M. Rudin;John T. Poirier;Lauren Averett Byers;Caroline Dive

  • Small-cell lung cancer.

    Charles M. Rudin;Elisabeth Brambilla;Corinne Faivre-Finn;Julien Sage

  • Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

    Marina Sirota;Joel T. Dudley;Joel T. Dudley;Jeewon Kim;Annie P. Chiang;Annie P. Chiang

  • Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization

    Julien Sage;George J. Mulligan;Laura D. Attardi;Abigail Miller

  • Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

    Triparna Sen;B. Leticia Rodriguez;Limo Chen;Carminia Della Corte

  • Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

    Julien Sage;Abigail L. Miller;Pedro A. Pérez-Mancera;Julianne M. Wysocki

  • Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

    Eric E. Gardner;Eric E. Gardner;Benjamin H. Lok;Valentina E. Schneeberger;Patrice Desmeules

  • From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling

    Panagiotis Ntziachristos;Jing Shan Lim;Julien Sage;Iannis Aifantis;Iannis Aifantis

  • Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer

    Jing Shan Lim;Alvaro Ibaseta;Marcus M. Fischer;Belinda Cancilla

  • CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

    Kipp Weiskopf;Nadine S. Jahchan;Peter J. Schnorr;Sandra Cristea

  • SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

    Pawel K. Mazur;Nicolas Reynoird;Purvesh Khatri;Pascal W. T. C. Jansen

  • Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

    Pawel K Mazur;Alexander Herner;Stephano S Mello;Matthias Wirth

  • A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

    Nadine S. Jahchan;Joel T. Dudley;Pawel K. Mazur;Natasha Flores

  • pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4a tumor suppressor gene

    Yojiro Kotake;Ru Cao;Patrick Viatour;Julien Sage

  • Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility

    Sarah K. Denny;Dian Yang;Chen Hua Chuang;Jennifer J. Brady

  • PDGF signalling controls age-dependent proliferation in pancreatic β-cells

    Hainan Chen;Xueying Gu;Yinghua Liu;Jing Wang

  • pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding

    Yojiro Kotake;Ru Cao;Patrick Viatour;Julien Sage

Frequent Co-Authors

Purvesh Khatri
Purvesh Khatri Stanford University
François Cuzin
François Cuzin Université Côte d'Azur
Roland M. Schmid
Roland M. Schmid Technical University of Munich
Elisabeth Brambilla
Elisabeth Brambilla Grenoble Alpes University
Or Gozani
Or Gozani Stanford University
Irving L. Weissman
Irving L. Weissman Stanford University
Charles M. Rudin
Charles M. Rudin Memorial Sloan Kettering Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Atul J. Butte
Atul J. Butte University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Julien Sage

Trending Scientists